First evaluation of coagulation analyzer ACL-Futura;Primera evaluación del analizador de coagulación ACL-Futura

Sangre

Volumn 41, Issue 6, 1996, Pages 417-426

  Aulesa, C ^a   Petit, M ^a   Sentis, M ^a   Ortega, J J ^a  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTITHROMBIN III; BILIRUBIN; FIBRINOGEN; HEPARIN; LIPID; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHILD; COLORIMETRY; DRUG EFFECT; ECONOMICS; EVALUATION; FEMALE; HUMAN; INSTRUMENTATION; MALE; NEWBORN; PHOTOMETRY; PREGNANCY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ACENOCOUMAROL; ADULT; ANTITHROMBIN III; ASPIRIN; BILIRUBIN; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CHILD; COLORIMETRY; EVALUATION STUDIES; FEMALE; FIBRINOGEN; HEPARIN; HUMANS; INFANT, NEWBORN; LIPIDS; MALE; NEPHELOMETRY AND TURBIDIMETRY; PREGNANCY; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030342642     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Poller L, Thomson JM, Taberner DA. Effect of automation on prothrombin time test in NEQAS surveys. J Clin Pathol 1989, 42 688- 699
2. Martinez Brotons F Situación actual de la automatización de las pruebas decoagulación. Sangre 1991; 36, 3: 217-219.
3. Dixon JS, Musgrove KA. Special laboratory evaluation of coagulation. Clinical Hematology, Lipp incott Company, Philadelphia, 1992; 611- 15
4. Quick AJ Clinical interpretation of one-stage prothrombin time.Circulation 1961; 24: 1422.
5. Loeliger EA, Poller L, Samama M, Thomson JM. Questions and answers or prothrombin time standaritation in oral anticoagulant control Thromb Haemostas 1985; 54: 515.
6. Rosse E, Mondonico P, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thrombosis Reseach 1988; 52: 453-468.
7. Koepke JA, Partial Thromboplastin Time test. Proposed Performance Guidelines.Thromb Haemostas 1986; 55, 143-144.
8. Stevenson XJ, Easton AC, Curry A,Thomson JM, Poller L.The Reliability of Activated Partial Thromboplastin Time Methods and the relationship to lipid composition and ultrastructure.Thromb Haemostas 1986; 55: 250-258
9. Abildgaard U, Lie M, Odegard OR. Antithrombin heparin cofactor) assay with new chromogenic substrates. Thromb Res 1977; 11: 549.
10. Claus A. Gerinnugphysiologische Schnellmethode wur Bestimmung des Fibrinogens.Acta Haemat 1957; 17: 237-246
11. Bablok W. Application of statistical procedures in analytical instrument testing. J Clin Lab Automation 1985, 7: 74-79.
12. ICSH. Protocol for evaluation of automated blood cell counters.Clin Lab Haematol 1983; 6: 69-84.
13. NCCLS. Collection,transport and processing of blood specimens for coagulation testing and performance of coagulation assays.NCCLS document H21-A2 1986; 3: vol. 11, n° 23.
14. ECCLS Guidelines for the a valuation of analysers in clinical chemistry. ECCLS Document 1986; 35: 357-362.
15. Jou JM, Pastor C, Aymerich M, Villamor JL, Vives Corrons JL. Primera evaluación del analizador hematológico Technicon H2. Sangre 1990; 35: 357-362.
16. Van de Basselar AMHP, Meeuwisse-Braun J, Bertin RM. Monitoring heparin therapy relationship between the activated partial thromboplastin time and heparin assay based on ex-vivo heparine samples.Thromb Haemostas 1990; 63: 16-13.